Laura Diluvio

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program.

Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: May 07, 2026

The role of dupilumab in skin microbiome shifts in the Netherton genodermatosis: a case report and review of literature.

The role of dupilumab in skin microbiome shifts in the Netherton genodermatosis: a case report and review of literature.

Journal: Frontiers in medicine

Published: April 12, 2026

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 11, 2026

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Journal: American journal of clinical dermatology

Published: November 05, 2025

A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes.

A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes.

Journal: Journal of clinical medicine

Published: October 04, 2025

Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series.

Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series.

Journal: Dermatology practical & conceptual

Published: June 12, 2025

Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy.

Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy.

Journal: Clinics and practice

Published: June 09, 2025

Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.

Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.

Journal: Journal of clinical medicine

Published: May 15, 2025

Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 28, 2025

Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real-Life Experience in the Lazio Region.

Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real-Life Experience in the Lazio Region.

Journal: International journal of dermatology

Published: January 26, 2025

Patient-reported outcome measures for chronic spontaneous urticaria: a strategy centred on optimizing patient management.

Patient-reported outcome measures for chronic spontaneous urticaria: a strategy centred on optimizing patient management.

Journal: Clinical and experimental dermatology

Published: November 04, 2024

Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient.

Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient.

Journal: Dermatology reports

Published: October 10, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026